These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 8915849

  • 1. Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes.
    Gottlieb S, Hayes E, Gilleaudeau P, Cardinale I, Gottlieb AB, Krueger JG.
    J Cutan Pathol; 1996 Oct; 23(5):404-18. PubMed ID: 8915849
    [Abstract] [Full Text] [Related]

  • 2. Acitretin : A Review of its Pharmacology and Therapeutic Use.
    Pilkington T, Brogden RN.
    Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 28421560
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH, van Vlijmen I, van Erp PE, de Jong EM, van de Kerkhof PC.
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [Abstract] [Full Text] [Related]

  • 7. Dimethylfumarate for psoriasis: Pronounced effects on lesional T-cell subsets, epidermal proliferation and differentiation, but not on natural killer T cells in immunohistochemical study.
    Bovenschen HJ, Langewouters AM, van de Kerkhof PC.
    Am J Clin Dermatol; 2010 Apr; 11(5):343-50. PubMed ID: 20553063
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Response of psoriasis to a new topical retinoid, AGN 190168.
    Esgleyes-Ribot T, Chandraratna RA, Lew-Kaya DA, Sefton J, Duvic M.
    J Am Acad Dermatol; 1994 Apr; 30(4):581-90. PubMed ID: 7512583
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
    Lauharanta J, Geiger JM.
    Br J Dermatol; 1989 Jul; 121(1):107-12. PubMed ID: 2527054
    [Abstract] [Full Text] [Related]

  • 14. Keratin polypeptide profile in psoriatic epidermis normalized by treatment with etretinate (aromatic retinoid Ro 10-9359).
    Staquet MJ, Faure MR, Reano A, Viac J, Thivolet J.
    Arch Dermatol Res; 1983 Jul; 275(2):124-9. PubMed ID: 6191725
    [Abstract] [Full Text] [Related]

  • 15. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
    Smit JV, de Jong EM, van Hooijdonk CA, Otero ME, Boezeman JB, van de Kerkhof PC.
    J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop.
    Terui T, Ozawa M, Tagami H.
    Exp Dermatol; 2000 Feb; 9(1):1-10. PubMed ID: 10688368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.